Oncology Models | Charles River Discovery Services

Primary Human Tumor Grafts 

Charles River Discovery Services is aggressively building a primary human tumor graft portfolio and we expect to have validated models available in 2011. This platform is designed to deliver:

  • Early passage cryopreservation
  • Broad panels of 10 solid tumors
  • Sensitivity and resistance profiles
  • Expression and mutation profiles


Tumor samples will be available for custom analysis. For more information about our primary human tumor grafts, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.